Searchable abstracts of presentations at key conferences in endocrinology

ea0038p223 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Measuring the contribution of de novo lipogenesis to fatty liver disease: a mouse and translational human study using high resolution mass spectrometry

Sanders Francis , Harvey Matthew , Ament Zsuzsanna , Tingley Jessie , Vacca Michele , Griffin Julian

De novo lipogenesis (DNL) is recognised as potentially contributory to pathogenesis of non-alcoholic fatty liver disease (NAFLD), and could be a factor in the progression of simple steatosis to steatohepatitis, although it contributes a relatively minor amount of whole body fat compared to dietary lipid. Consequently understanding the lipidome during induced DNL may provide insight into potential biomarkers of DNL that could be clinically relevant in those at risk of ...

ea0016p517 | Obesity | ECE2008

Increased unsaturated fatty acids biosynthesis when pyruvate carboxylase is suppressed in adipocytes

Slawik Marc , Jitrapakdee Sarawut , Atherton Helen , Hadaschick Dirk , Kimber Wendy L , Considine Robert , Wallace John C , Sethi Jaswinder K , O'Rahilly Stephen , Griffin Julian L , Vidal-Puig Antonio

To maintain a proper lipid composition of cellular membranes is fundamental for cell viability and intracellular signalling. Therefore we hypothesised the existence of membrane quality control homeostatic mechanisms. Previously, we have shown that Pyruvate Carboxylase (PC), an enzyme involved in de novo lipogenesis and fuel partitioning, is a target of PPARĪ³ and that PC level is decreased in PPARĪ³ KO and obese insulin resistant mouse models. Here, we used RNAi...